Related Experiment Video
Updated: Jul 19, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
[Sepsis: from pathophysiology to treatment].
L Gesualdo1, P Cirillo, S Netti
1Dipartimento di Scienze Biomediche e BIOAGROMED, Università di Foggia. l.gesualdo@unifg.it
Improving outcomes for severe sepsis and septic shock requires collaboration to develop new treatments. Future research on early diagnostic biomarkers and prognostic indicators is crucial for timely intervention and better understanding of septic syndrome.
Area of Science:
- Critical care medicine
- Biomedical engineering
- Translational research
Context:
- Severe sepsis and septic shock remain significant causes of mortality.
- Current treatment strategies necessitate improvement to reduce high mortality rates.
Purpose:
- To highlight the need for multidisciplinary collaboration in developing novel treatments for sepsis.
- To emphasize the importance of new biomarkers and prognostic indicators for early diagnosis and effective management.
Summary:
- Multidisciplinary cooperation among basic, clinical, and industrial researchers is essential for advancing the treatment of septic syndrome.
- Development of artificial or biological devices is key to addressing sepsis and its systemic complications.
- Future advancements in early diagnostic biomarkers and prognostic monitoring are critical for improving patient outcomes.
Impact:
- Enhanced understanding of septic syndrome mechanisms.
- Facilitation of timely and effective therapeutic interventions.
- Potential reduction in mortality rates associated with severe sepsis and septic shock.
Related Concept Videos
Urinary Tract Infection II: Pathophysiology
Asepsis
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia II: Pathophysiology
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
